Switch to
More onapp

Ganga Pharmaceuticals Ltd

GANGAPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3 cr, stock is ranked 4,009
Moderate RiskStock is 2.37x as volatile as Nifty
9.700.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3 cr, stock is ranked 4,009
Moderate RiskStock is 2.37x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
65.66
PB RatioPB Ratio
0.73
Dividend YieldDiv. Yield
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ganga Pharmaceuticals Limited is an India-based company, which is engaged in the business of manufacturing and trading in pharmaceuticals and allied products. The Company is a producer, marketer and distributor of bulk ayurvedic medicines in Mumbai. The Company manufactures approximately 230 products. The Company offers medicine for acidity, antidandruff, antioxidants, blood purifier & skin disorder, constipation, cough and cold, dental care, diarrhea, ear care, female tonic, hair care, hemorrhoids and piles, herbal cosmetics, indigestion, iron tonic, joint pains, kidney stone, liver disorder, rejuvenation tonic, sleep inducers, and weight management. The Company’s products include ASUKA TABLETS, ASUKA TABLETS, ASHWO TABLETS-TONIC FOR BODY AND MIND, RAKTAJ TABLETS / SYRUP-FOR SKIN DISORDERS, NIRMALAYA (PROPRIETORY), DANTA DOSHAHAR MANJAN, HOLETRICA CAPSULE, FEMOHERB SYRUP/TABLETS, MAHABHRUNGRAJ OIL and other.

Financial TrendFinancial statements 

20192020202120223.503.252.622.750.180.200.010.06
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Board Meeting 
Announced OnOct 29, 2022

Ganga Pharmaceuticals Ltd - 539680 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Friday November 11,2022 | Download

Ganga Pharmaceuticals Ltd - 539680 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Friday November 11,2022 | Download

See all events